Literature DB >> 3278829

Open rhinoplasty.

R P Gruber1.   

Abstract

Open rhinoplasty provides visualization, which for many is essential for the best sculpturing. The indications for its use include every primary and secondary rhinoplasty candidate unless tip grafts are going to be under tension or if the deformity is minor. The technique of opening the nose has been described. Emphasis is placed on (1) suturing the medial crura together, (2) suturing the medial crura to the septum, (3) resecting a portion of the lateral crus, and (4) leaving as much cartilage in the supratip and cephalic parts of the lateral crus as possible. The result is (1) greater tip projection with fewer tip grafts, (2) improved correction of tip convexity, (3) fewer supratip deformities, and (4) fewer Weir excisions. The columella scar is usually inconspicuous and has not been a significant problem in any case.

Entities:  

Mesh:

Year:  1988        PMID: 3278829

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  5 in total

1.  [The crooked nose: correction of dorsal and caudal septal deviations].

Authors:  H M T Foda
Journal:  HNO       Date:  2010-09       Impact factor: 1.284

Review 2.  Value of cephalic part of lateral crus in functional rhinoplasty.

Authors:  Amir A Sazgar; Amin Amali; Mina Najarzad Peyvasty
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12-24       Impact factor: 2.503

3.  Nasal bone grafts from the removed hump used as overlay grafts to camouflage concave lateral crura.

Authors:  Utku Kubilay; Suleyman Erdogdu; Ozan Seymen Sezen
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-03-22

Review 4.  Calibrated nasal tip: review of 100 cases.

Authors:  A de la Fuente; J L Martin del Yerro
Journal:  Aesthetic Plast Surg       Date:  1994       Impact factor: 2.326

5.  The role of septal surgery in cosmetic rhinoplasty.

Authors:  C Parrilla; A Artuso; R Gallus; J Galli; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-06       Impact factor: 2.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.